| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | $77.4M | 11.3M | ▲+0.1% Added · +7K sh | Q1 2026 | |
| 2 | MPM BioImpact LLC | $17.8M | 2.6M | ▼−2.9% Reduced · −78K sh | Q1 2026 | |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | $13.1M | 1.9M | ▼−0.3% Reduced · −7K sh | Q1 2026 | |
| 4 | BRAIDWELL LP | $10.5M | 1.5M | ▲New +1.5M sh | Q1 2026 | |
| 5 | GREAT POINT PARTNERS LLC | $9.1M | 1.3M | ▲+36% Added · +355K sh | Q1 2026 | |
| 6 | MILLENNIUM MANAGEMENT LLC | $8.7M | 1.3M | ▲+331% Added · +980K sh | Q1 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $8.1M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 8 | Kynam Capital Management, LP | $6.9M | 1.0M | ▼−2.4% Reduced · −25K sh | Q1 2026 | |
| 9 | MARSHALL WACE, LLP | $5.3M | 773K | ▲+154% Added · +469K sh | Q1 2026 | |
| 10 | Affinity Asset Advisors, LLC | $4.8M | 700K | ▼−46% Reduced · −600K sh | Q1 2026 | |
| 11 | ADAR1 Capital Management, LLC | $4.1M | 598K | ▼−58% Reduced · −835K sh | Q1 2026 | |
| 12 | SPHERA FUNDS MANAGEMENT LTD. | $2.9M | 419K | ▼−55% Reduced · −513K sh | Q1 2026 | |
| 13 | BlackRock, Inc. | $2.8M | 402K | ▲+3.2% Added · +12K sh | Q1 2026 | |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.7M | 387K | ▼−13% Reduced · −58K sh | Q1 2026 | |
| 15 | CITADEL ADVISORS LLC | $2.4M | 346K | ▲+45% Added · +107K sh | Q1 2026 | |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | $2.1M | 313K | ▲+0.7% Added · +2K sh | Q1 2026 | |
| 17 | TWO SIGMA INVESTMENTS, LP | $2.1M | 311K | ▼−45% Reduced · −256K sh | Q1 2026 | |
| 18 | DIADEMA PARTNERS LP | $2.0M | 286K | ▲New +286K sh | Q1 2026 | |
| 19 | TD ASSET MANAGEMENT INC | $1.7M | 250K | ▲+1.6% Added · +4K sh | Q1 2026 | |
| 20 | MORGAN STANLEY | $1.6M | 234K | ▲+58% Added · +86K sh | Q1 2026 | |
| 21 | Longaeva Partners L.P. | $1.5M | 218K | ▲New +218K sh | Q1 2026 | |
| 22 | RENAISSANCE TECHNOLOGIES LLC | $1.5M | 217K | ▼−32% Reduced · −103K sh | Q1 2026 | |
| 23 | JANE STREET GROUP, LLC | $1.2M | 171K | ▼−8.6% Reduced · −16K sh | Q1 2026 | |
| 24 | VANGUARD FIDUCIARY TRUST CO | $1.1M | 159K | ▲New +159K sh | Q1 2026 | |
| 25 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.1M | 156K | ▲+11% Added · +16K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 11 funds | $5.6B |
| ALPHABET INC-CL AGOOGL | 11 funds | $2.8B |
| ELI LILLY & COLLY | 11 funds | $1.1B |
| UNITEDHEALTH GROUP INCUNH | 11 funds | $900.7M |
| BOOKING HOLDINGS INCBKNG | 11 funds | $519.8M |
| VENTYX BIOSCIENCES INCVTYXUSD | 11 funds | $0 |
| NVIDIA CORPNVDA | 10 funds | $8.5B |
| MICROSOFT CORPMSFT | 10 funds | $4.2B |
| BROADCOM INCAVGO | 10 funds | $2.9B |
| META PLATFORMS INC-CLASS AMETA | 10 funds | $2.6B |
| ALPHABET INC-CL CGOOG | 10 funds | $2.3B |
| COSTCO WHOLESALE CORPCOST | 10 funds | $1.5B |
Ranked by how many of CLYM's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Brennan Aoife | President and CEO, Director | Sell (S) | 31K | $407K |
| Feb 26, 2026 | Thomas Stephen Basil | Director | Sell (S) | 16K | $114K |
| Feb 25, 2026 | Thomas Stephen Basil | Director | Sell (S) | 34K | $236K |
| Feb 13, 2026 | Thomas Stephen Basil | Director | Sell (S) | 10K | $58K |
| Feb 12, 2026 | Thomas Stephen Basil | Director | Sell (S) | 90K | $471K |
| Jan 5, 2026 | RA Capital Healthcare Fund LP | Director, 10% Owner | Buy (P) | 7K | $25K |
| Dec 12, 2025 | Kolchinsky Peter | Director, 10% Owner | Buy (P) | 101K | $290K |
| Dec 11, 2025 | Kolchinsky Peter | Director, 10% Owner | Buy (P) | 213K | $465K |
| Jun 30, 2025 | Brennan Aoife | President and CEO, Director | Sell (S) | 21K | $25K |
| Jun 20, 2025 | Pimblett Emily | SVP, Finance & CAO | Sell (S) | 1K | $2K |
| Mar 20, 2025 | Pimblett Emily | SVP, Finance & CAO | Sell (S) | 1K | $2K |
| Dec 19, 2024 | Pimblett Emily | CHIEF ACCOUNTING OFFICER | Sell (S) | 1K | $2K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CLYM/capital-change-brief"
Use Arkolith's capital_change_brief for CLYM. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CLYM. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.